Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
SUMMARY: Anti-Wolbachia therapy delivers safe macrofilaricidal activity with superior therapeutic outcomes compared to all standard anti-filarial treatments, with the added benefit of substantial improvements in clinical pathology. These outcomes can be achieved, in principle, with existing registered drugs, e.g. doxycycline, that are affordable, available to endemic communities and have well known, albeit population-limiting, safety profiles. The key barriers to using doxycycline as an mass drug administration (MDA) strategy for widespread community-based control are the logistics of a relatively lengthy course of treatment (4–6 weeks) and contraindications in children under eight years and pregnancy. Therefore, the primary goal of the anti-Wolbachia (A·WOL) consortium is to find drugs and regimens that reduce the period of treatment from weeks to days (7 days or less), and to find drugs which would be safe in excluded target populations (pregnancy and children). A secondary goal is to refine regimens of existing antibiotics suitable for a more restricted use, prior to the availability of a regimen that is compatible with MDA usage. For example, for use in the event of the emergence of drug-resistance, in individuals with high loiasis co-infection and at risk of severe adverse events (SAE) to ivermectin, or in post-MDA ‘endgame scenarios’, where test and treat strategies become more cost effective and deliverable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686 · cited 5×
“Anti-Wolbachia therapy delivers safe macro fi lar-icidal activity with superior therapeutic outcomes compared to all standard anti-fi larial treatments, with the added bene fi t of substantial improvements in clinical pathology (Taylor et al. 2010; Tamarozzi et al. 2011).”
InfluentialSelf-citationTurner, J. D., Langley, R. S., Johnston, K. L., Gentil, K., Ford, L., Wu, B., Graham, M., Sharpley, F., Slatko, B., Pearlman, E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901528200 · Cited by 139 · cited 2×
“…by the Bill & Melinda Gates Foundation to search for new drugs active against Wolbachia that are suitable for community-directed MDA with a secondary goal to optimize regimens of existing drugs and re-purposed registered drugs for use in more restricted target populations (http://www.a-wol.net).”
BackgroundSelf-citationLandmann, F., Voronin, D., Sullivan, W., & Taylor, M. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002351 · Cited by 134
Self-citationWolbachia filarial interactions: Wolbachia filarial cellular and molecular interactions
Taylor, M. J., Voronin, D., Johnston, K. L., & Ford, L. (2013) · Cellular Microbiology · doi:10.1111/cmi.12084 · Cited by 97
Self-citation
Cited by
Van Voorhis, W. C., Adams, J. H., Adelfio, R., Ahyong, V., Akabas, M. H., Alano, P., Alday, A., Alemán Resto, Y., Alsibaee, A., Alzualde, A., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005763 · Cited by 435
Self-citationMoxidectin: an oral treatment for human onchocerciasis
Milton, P., Hamley, J. I. D., Walker, M., & Basáñez, M.-G. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792772 · Cited by 211
Mansonellosis: current perspectives
Ta-Tang, T.-H., Crainey, J., Post, R. J., Luz, S. L., & Rubio, J. (2018) · Research and Reports in Tropical Medicine · doi:10.2147/rrtm.s125750 · Cited by 101
Klarmann-Schulz, U., Specht, S., Debrah, A. Y., Batsa, L., Ayisi-Boateng, N. K., Osei-Mensah, J., Mubarik, Y., Konadu, P., Ricchiuto, A., Fimmers, R., et al. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005156 · Cited by 63
Self-citationFinding Wolbachia in Filarial larvae and Culicidae Mosquitoes in Upper Egypt Governorate
Dyab, A. K., Galal, L. A., Mahmoud, A. E., & Mokhtar, Y. (2016) · The Korean Journal of Parasitology · doi:10.3347/kjp.2016.54.3.265 · Cited by 13
“This will allow the development of new therapeutic approaches to filariae [25,26].”
Background
Metadata
- Authors
- TAYLOR, M. J., HOERAUF, A., TOWNSON, S., SLATKO, B. E., & WARD, S. A.
- Venue
- Parasitology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-07-18
- Volume
- 141
- Issue
- 1
- Pages
- 119-127
- ISSN
- 0031-1820 (ISSN-L)
- 1469-8161
- OpenAlex
- W2039472587
- Cited by
- 143
- References
- 4
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. https://app.cochat.ai/papers/10.1017/s0031182013001108
- The paper
- TAYLOR, M. J., HOERAUF, A., TOWNSON, S., SLATKO, B. E., & WARD, S. A. (2014). Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Parasitology. https://doi.org/10.1017/s0031182013001108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.